Zhenzhai Cai

436 total citations
26 papers, 293 citations indexed

About

Zhenzhai Cai is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Zhenzhai Cai has authored 26 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Zhenzhai Cai's work include Pancreatic and Hepatic Oncology Research (3 papers), Hedgehog Signaling Pathway Studies (3 papers) and Calpain Protease Function and Regulation (2 papers). Zhenzhai Cai is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Hedgehog Signaling Pathway Studies (3 papers) and Calpain Protease Function and Regulation (2 papers). Zhenzhai Cai collaborates with scholars based in China, Australia and United States. Zhenzhai Cai's co-authors include Zhanxiong Xue, Lingling Zhou, Wencan Wu, Lu Yan, Feng Yuan, Shulei Chou, Pingping Huang, Yong Liu, Lingdan Kong and Tom Lawson and has published in prestigious journals such as Clinical Cancer Research, Small and Annals of Oncology.

In The Last Decade

Zhenzhai Cai

26 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenzhai Cai China 12 110 84 64 47 46 26 293
Kun Mi China 11 152 1.4× 117 1.4× 62 1.0× 37 0.8× 43 0.9× 19 355
Wu‐tong Ju China 11 128 1.2× 147 1.8× 44 0.7× 50 1.1× 48 1.0× 27 358
Jane Rogan United Kingdom 8 125 1.1× 104 1.2× 92 1.4× 16 0.3× 35 0.8× 15 358
Wanting Hou China 9 108 1.0× 121 1.4× 36 0.6× 42 0.9× 73 1.6× 15 289
Ao Yu United States 9 186 1.7× 81 1.0× 94 1.5× 55 1.2× 30 0.7× 16 368
Gregory M. Cresswell United States 9 121 1.1× 83 1.0× 77 1.2× 114 2.4× 74 1.6× 17 348
Lanqing Cao China 10 121 1.1× 66 0.8× 48 0.8× 15 0.3× 60 1.3× 21 281
Shasha He China 7 152 1.4× 45 0.5× 41 0.6× 30 0.6× 29 0.6× 11 282

Countries citing papers authored by Zhenzhai Cai

Since Specialization
Citations

This map shows the geographic impact of Zhenzhai Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenzhai Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenzhai Cai more than expected).

Fields of papers citing papers by Zhenzhai Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenzhai Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenzhai Cai. The network helps show where Zhenzhai Cai may publish in the future.

Co-authorship network of co-authors of Zhenzhai Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenzhai Cai. A scholar is included among the top collaborators of Zhenzhai Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenzhai Cai. Zhenzhai Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Hao, et al.. (2025). CCT8 drives colorectal cancer progression via the RPL4-MDM2-p53 axis and immune modulation. BMC Medical Genomics. 18(1). 77–77. 2 indexed citations
2.
Xu, Ruoshi, et al.. (2024). Potential application of ChatGPT in Helicobacter pylori disease relevant queries. Frontiers in Medicine. 11. 1489117–1489117. 1 indexed citations
3.
Lu, Xinliang, Zhengbo Song, Xianghui Kong, et al.. (2024). Proton pump inhibitors enhance macropinocytosis‐mediated extracellular vesicle endocytosis by inducing membrane v‐ATPase assembly. Journal of Extracellular Vesicles. 13(4). e12426–e12426. 14 indexed citations
4.
Lin, Yi‐Ying, et al.. (2024). Application and value of anxiety and depression scale in patients with functional dyspepsia. BMC Psychology. 12(1). 244–244. 1 indexed citations
5.
Luo, Yue, Hao Wu, Yating Shen, et al.. (2023). PF-04449913 Inhibits Proliferation and Metastasis of Colorectal Cancer Cells byDown-regulating MMP9 Expression through the ERK/p65 Pathway. Current Molecular Pharmacology. 17. e150923221164–e150923221164. 10 indexed citations
7.
He, Ling‐Yun, Jiamin Chen, Jinfeng Wang, et al.. (2023). Three-dimensional core-shell alginate microsphere for cancer hypoxia simulation in vitro. Frontiers in Bioengineering and Biotechnology. 11. 1174206–1174206. 5 indexed citations
8.
Li, Liyi, Chenchen Mao, Xiangyang Xue, et al.. (2023). Preliminary clinical study of personalized neoantigen vaccine therapy for microsatellite stability (MSS)-advanced colorectal cancer. Cancer Immunology Immunotherapy. 72(7). 2045–2056. 17 indexed citations
9.
10.
Zhang, Jing, Leyi Ni, Zhanxiong Xue, et al.. (2021). Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer. Human Vaccines & Immunotherapeutics. 18(1). 1–11. 22 indexed citations
11.
Kong, Lingdan, Feng Yuan, Pingping Huang, et al.. (2020). A Metal–Polymer Hybrid Biomimetic System for use in the Chemodynamic‐Enhanced Photothermal Therapy of Cancers. Small. 16(43). e2004161–e2004161. 54 indexed citations
13.
Zhou, Lingling, et al.. (2018). High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients. Clinical & Translational Oncology. 21(7). 924–932. 16 indexed citations
14.
He, Yun, Shouxing Yang, Lingling Zhou, et al.. (2017). High expression of atonal homolog 8 predicts a poor clinical outcome in patients with colorectal cancer and contributes to tumor progression. Oncology Reports. 37(5). 2955–2963. 14 indexed citations
15.
He, Yun, Lingling Zhou, Yunfeng Shan, et al.. (2016). High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer. International Journal of Oncology. 50(2). 396–404. 13 indexed citations
16.
Cai, Zhenzhai, Kezhi Lin, Shuzhi Zheng, et al.. (2016). Human cytomegalovirus-encoded US28 may act as a tumor promoter in colorectal cancer. World Journal of Gastroenterology. 22(9). 2789–2789. 21 indexed citations
17.
Cai, Zhenzhai, et al.. (2015). Inactivation of Rab23 inhibits the invasion and motility of pancreatic duct adenocarcinoma. Genetics and Molecular Research. 14(1). 2707–2715. 11 indexed citations
18.
Xue, Zhanxiong, Yuhui Zhou, Cheng Wang, et al.. (2015). Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma. Oncology Reports. 35(1). 50–58. 8 indexed citations
19.
Xue, Zhanxiong, Zhiqiang Zheng, Xiaohua Ye, et al.. (2014). Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells. World Journal of Surgical Oncology. 12(1). 404–404. 9 indexed citations
20.
Cai, Zhenzhai, Zheng Lu, Yan-fang Gong, et al.. (2009). A novel approach for treatment of unresectable extrahepatic bile duct carcinoma: design of radioactive stents and an experimental trial in healthy pigs. Gastrointestinal Endoscopy. 69(3). 517–524. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026